Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / LPTX - Leap Therapeutics Initiates Trial And Other News: The Good Bad And Ugly Of Biopharma

LPTX - Leap Therapeutics Initiates Trial And Other News: The Good Bad And Ugly Of Biopharma

Leap Therapeutics Inc.
  • Leap Therapeutics initiates Phase 2a trial for DKN-01.
  • MacroGenics reports progress on MGA012 development.
  • BridgeBio Pharma starts Phase 2 encaleret trial.

For further details see:

Leap Therapeutics Initiates Trial, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Leap Therapeutics Inc.
Stock Symbol: LPTX
Market: NASDAQ
Website: leaptx.com
Menu
LPTX LPTX Quote LPTX Short LPTX News LPTX Articles LPTX Message Board
Get LPTX Alerts

News, Short Squeeze, Breakout and More Instantly...